SEC Form 4 · accession 0001209191-18-028454
Conatus Pharmaceuticals Inc. · CNAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven J Mento
Officer — President, CEO & Director · Director
Period of report
May 4, 2018
Accepted (ET)
May 7, 2018 · 7:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001383701
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 4, 2018 | M | 60,000 | $0.99 | A | 60,000 | D | |
| Common StockF1 | holding | — | — | — | 427,083 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.99 | May 4, 2018 | M | 60,000 | D | Feb 17, 2011 | Feb 16, 2021 | Common Stock | 60,000 | 147,070 | D |
Explanation of responses
- F1Held by a family trust of which Dr. Mento is a trustee.